Moutaz Ghrewati, MD
Board Certifications: Advanced Cardiac Life Support, Internal Medicine and Medical Doctor
Specializations: Hematology and Medical Oncology
Languages: Arabic, English, Spanish and Turkish
Locations: Hackensack, NJ
Throughout his career, Dr. Ghrewati has worked to create nurturing relationships with his patients, regardless of cultural, ethnic and socioeconomic backgrounds, while building strong partnerships with health care professionals. He promotes individual-centered care with an interest in bone marrow and cellular therapy and applies an up-to-date awareness of national care management trends while exhibiting astute knowledge and professionalism.
Education
Medical Education
University of Kalamoon — Faculty of Medicine, Syrian Arab Republic
St. Joseph’s Regional Medical Center, Paterson, New Jersey
RESIDENCY
St. Joseph’s Regional Medical Center, Paterson, New Jersey, Internal Medicine
HOSPITALIST
St. Joseph’s Wayne Hospital, Wayne, New Jersey, Internal Medicine
FELLOWSHIPS
St. Joseph’s Regional Medical Center, Paterson, New Jersey, Hematology/Oncology
OBSERVERSHIP
Awards and honors
AWARDS AND HONORS
- Resident Gold Humanism Honor Society (GHHS) Award – NYMC (June 2020)
- Top 10 Students of Medicine (2007 – 2014) / Top 3 Highest In-Service Exam Score (2018)
PROFESSIONAL MEMBERSHIPS
- American Medical Association
- American Society of Hematology
- Syrian American Medical Society
- American Society of Clinical Oncology
- American Society of Transplant and Cellular Therapy
HOSPITAL AFFILIATIONS
- Joseph’s University Medical center
- St. Joseph’s Wayne General Hospital
- Hackensack University Medical Center
we are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.